1. Home
  2. HMN vs ABCL Comparison

HMN vs ABCL Comparison

Compare HMN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horace Mann Educators Corporation

HMN

Horace Mann Educators Corporation

HOLD

Current Price

$54.94

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$7.90

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMN
ABCL
Founded
1945
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
HMN
ABCL
Price
$54.94
$7.90
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$47.33
$8.40
AVG Volume (30 Days)
291.8K
6.9M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.05%
N/A
EPS Growth
57.26
10.91
EPS
1.00
N/A
Revenue
$1,701,400,000.00
$75,128,000.00
Revenue This Year
$6.91
N/A
Revenue Next Year
$3.41
$21.85
P/E Ratio
$54.12
N/A
Revenue Growth
6.66
160.56
52 Week Low
$40.04
$2.75
52 Week High
$54.64
$8.42

Technical Indicators

Market Signals
Indicator
HMN
ABCL
Relative Strength Index (RSI) 82.02 68.74
Support Level $41.94 $3.38
Resistance Level N/A N/A
Average True Range (ATR) 1.27 0.65
MACD 0.42 0.17
Stochastic Oscillator 91.80 84.55

Price Performance

Historical Comparison
HMN
ABCL

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: